Meridew, Jeffrey
Mayo Clinic
Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.
Citations 1
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Haak, Andrew J. , Kostallari, Enis , Sicard, Delphine , Ligresti, Giovanni , Choi, Kyoung Moo , Caporarello, Nunzia , Jones, Dakota L. , Tan, Qi , Meridew, Jeffrey A., Espinosa, Ana M. Diaz , Aravamudhan, Aja, Maiers, Jessica L. , Britt, Rodney D. , Roden, Anja C. , Prakash, Y. S. , Nouraie, Mehdi , Li, Xiaoyun , Lagares, David , Tager, Andrew M. , Varelas, Xaralabos , Shah, Vijay H. , Tschumperlin, Daniel J. , Zhang, Yingze , Meridew, Jeffrey, Diaz Espinosa, Ana M , Pabelick, Christina M , Prakash, Y S , Nouraie, Seyed Mehdi , Li, Xiaoyun , Zhang, Yingze , Lagares, David , Varelas, Xaralabos , Shah, Vijay H , Tschumperlin, Daniel J , Kostallari, Enis , Caporarello, Nunzia , Ligresti, Giovanni , Pabelick, Christina M. , Kass, Daniel J.
Science Translational Medicine | October 30, 2019 | Volume: 11 | Issue: 516 | Pages: No page available
Pharmacologic stimulation of a G protein–coupled receptor preferentially expressed on fibroblasts reverses experimental lung and liver fibrosis.